SCHEMBL13675249

SCHEMBL13675249

CCC(CC)(c1ccc(O)c(C)c1)c1cc(C)c(I)s1

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 19/20 0.62
ESR2 Q92731 7/20 0.62
AR P10275 3/20 0.62
VDR P11473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13672886 0.81 ESR1 (0.60) ESR1ESR2ARVDR
SCHEMBL3396335 0.78 ESR1 (0.57) ESR1ESR2ARVDR
SCHEMBL30058620 0.78 ESR1 (1.00) ESR1ESR2ARVDR
SCHEMBL837374 0.78 ESR1 (1.00) ESR1ESR2ARVDR
SCHEMBL3390972 0.77 ESR1 (0.78) ESR1ESR2ARVDR
SCHEMBL13675224 0.76 ESR1 (0.54) ESR1ESR2ARVDR
SCHEMBL3393188 0.76 ESR1 (0.54) ESR1ESR2ARVDR
SCHEMBL13203878 0.76 ESR1 (0.79) ESR1ESR2ARVDR
SCHEMBL3393109 0.75 ESR1 (0.53) ESR1ESR2ARVDR
SCHEMBL3388735 0.74 ESR1 (0.78) ESR1ESR2ARVDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601850-B2 less hypercalcemic than 1a,25 dihydroxy vitamin D3; bone disorders, psoriasis ELI LILLY AND COMPANY (US) 2009-10-13 US disclosed